AETHLON MEDICAL INC
For the period ended Mar 31, 2025. Filed Jun 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 26, 2025
AEMD$5.49+0.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
FOR THE YEARS ENDED MARCH 31, 2025 AND 2024
| COMMON STOCK · ADDITIONAL PAID IN · ACCUMULATED · ACCUMULATED COMPREHENSIVE · TOTAL | ||||||
|---|---|---|---|---|---|---|
| SHARES | AMOUNT | CAPITAL | DEFICIT | LOSS | EQUITY | |
| BALANCE - MARCH 31, 2023 | 287,408 | $288 | $157,428,617 | $(142,358,554) | $(6,141) | $15,064,210 |
| Issuances of common stock for cash under at the market program, net | 37,011 | 37 | 1,322,346 | – | – | 1,322,383 |
| Rounding for reverse split | 4 | – | – | – | – | – |
| Issuance of common shares upon vesting of restricted stock units and net stock option exercises | 4,305 | 4 | (34,782) | – | – | (34,778) |
| Reversal of accrued commission liability | – | – | 404,120 | – | – | 404,120 |
| Stock-based compensation expense | – | – | 1,219,370 | – | – | 1,219,370 |
| Net loss | – | – | – | (12,208,174) | – | (12,208,174) |
| Other comprehensive loss | – | – | – | (799) | (799) | |
| BALANCE – MARCH 31, 2024 | 328,728 | $329 | $160,339,671 | $(154,566,728) | $(6,940) | $5,766,332 |
| Issuances of common stock for public offering | 1,012,500 | 1,013 | 3,538,894 | – | – | 3,539,907 |
| Issuances of common stock for Class A and Class B warrant exercises, net | 1,231,304 | 1,231 | 4,205,173 | – | – | 4,206,404 |
| Issuance of common shares upon vesting of restricted stock units and net stock option exercises | 12,707 | 13 | (18,940) | – | – | (18,927) |
| Stock-based compensation expense | – | – | 415,234 | – | – | 415,234 |
| Warrant inducement expense, net | – | – | 4,612,862 | – | – | 4,612,862 |
| Net loss | – | – | – | (13,388,089) | – | (13,388,089) |
| Other comprehensive loss | – | – | – | – | (10,193) | (10,193) |
| BALANCE – MARCH 31, 2025 | 2,585,239 | $2,586 | $173,093,894 | $(167,954,817) | $(17,133) | $5,123,530 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.